Concepts (315)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Pityriasis Rosea | 6 | 2020 | 130 | 2.92 | Why? |
| Herpesvirus 7, Human | 5 | 2020 | 18 | 2.56 | Why? |
| Psoriasis | 9 | 2021 | 1739 | 2.26 | Why? |
| Roseolovirus Infections | 3 | 2020 | 131 | 2.12 | Why? |
| Skin Ulcer | 3 | 2021 | 98 | 1.62 | Why? |
| Herpesvirus 6, Human | 5 | 2020 | 162 | 1.61 | Why? |
| Hyperpigmentation | 2 | 2019 | 42 | 1.46 | Why? |
| Rosacea | 2 | 2020 | 57 | 1.43 | Why? |
| Hand, Foot and Mouth Disease | 3 | 2019 | 115 | 1.40 | Why? |
| Pemphigoid, Bullous | 2 | 2018 | 89 | 1.27 | Why? |
| Facial Dermatoses | 2 | 2020 | 222 | 1.21 | Why? |
| Th2 Cells | 2 | 2019 | 680 | 1.15 | Why? |
| Scleroderma, Systemic | 4 | 2019 | 583 | 1.04 | Why? |
| Exanthema | 3 | 2017 | 1097 | 1.03 | Why? |
| Skin Diseases | 4 | 2020 | 2509 | 0.95 | Why? |
| Sweat Gland Diseases | 1 | 2021 | 7 | 0.92 | Why? |
| Corynebacterium Infections | 1 | 2021 | 26 | 0.89 | Why? |
| Corynebacterium | 1 | 2021 | 47 | 0.88 | Why? |
| Serratia marcescens | 2 | 2017 | 38 | 0.86 | Why? |
| Hemangiosarcoma | 2 | 2018 | 24 | 0.86 | Why? |
| Keratosis, Actinic | 2 | 2017 | 54 | 0.83 | Why? |
| Dapsone | 1 | 2020 | 59 | 0.81 | Why? |
| Blister | 1 | 2021 | 119 | 0.81 | Why? |
| Livedo Reticularis | 1 | 2020 | 90 | 0.79 | Why? |
| Oral Ulcer | 1 | 2020 | 70 | 0.77 | Why? |
| Carcinoma, Squamous Cell | 2 | 2018 | 902 | 0.76 | Why? |
| Pemphigoid, Benign Mucous Membrane | 1 | 2018 | 9 | 0.76 | Why? |
| Morganella morganii | 1 | 2018 | 5 | 0.75 | Why? |
| Leprosy, Tuberculoid | 1 | 2018 | 2 | 0.75 | Why? |
| Gliclazide | 1 | 2018 | 13 | 0.75 | Why? |
| Francisella tularensis | 1 | 2018 | 28 | 0.74 | Why? |
| Vulva | 1 | 2018 | 31 | 0.74 | Why? |
| Blind Loop Syndrome | 1 | 2017 | 1 | 0.74 | Why? |
| Enterovirus A, Human | 2 | 2019 | 180 | 0.73 | Why? |
| Tularemia | 1 | 2018 | 25 | 0.73 | Why? |
| Wound Infection | 1 | 2019 | 66 | 0.73 | Why? |
| Diptera | 1 | 2018 | 30 | 0.73 | Why? |
| Virus Activation | 2 | 2020 | 480 | 0.73 | Why? |
| Eczema | 2 | 2019 | 227 | 0.72 | Why? |
| Lichen Planus | 1 | 2019 | 60 | 0.71 | Why? |
| Biological Therapy | 2 | 2021 | 456 | 0.71 | Why? |
| Interleukin-13 | 1 | 2019 | 204 | 0.71 | Why? |
| Mouth Diseases | 2 | 2018 | 193 | 0.70 | Why? |
| Insect Bites and Stings | 1 | 2018 | 63 | 0.69 | Why? |
| Interleukin-4 | 1 | 2019 | 367 | 0.69 | Why? |
| Treponema pallidum | 1 | 2017 | 42 | 0.69 | Why? |
| Penile Neoplasms | 1 | 2018 | 97 | 0.69 | Why? |
| Skin Diseases, Infectious | 1 | 2019 | 77 | 0.69 | Why? |
| Vitamin B Complex | 1 | 2017 | 49 | 0.68 | Why? |
| Coxsackievirus Infections | 1 | 2017 | 71 | 0.67 | Why? |
| Pregnancy Complications | 2 | 2018 | 1388 | 0.65 | Why? |
| Purpura | 1 | 2020 | 310 | 0.64 | Why? |
| Biological Products | 3 | 2021 | 2331 | 0.64 | Why? |
| Epithelium | 1 | 2018 | 330 | 0.63 | Why? |
| Receptors, Androgen | 1 | 2018 | 212 | 0.63 | Why? |
| Neuritis | 1 | 2018 | 109 | 0.62 | Why? |
| Epstein-Barr Virus Infections | 1 | 2020 | 366 | 0.62 | Why? |
| Autoimmune Diseases | 2 | 2021 | 1996 | 0.62 | Why? |
| Insect Vectors | 1 | 2018 | 227 | 0.61 | Why? |
| Ulcer | 1 | 2017 | 128 | 0.61 | Why? |
| Niacinamide | 1 | 2017 | 135 | 0.61 | Why? |
| Dermatitis | 1 | 2018 | 188 | 0.61 | Why? |
| Drug Substitution | 1 | 2019 | 385 | 0.60 | Why? |
| Nail Diseases | 1 | 2018 | 142 | 0.60 | Why? |
| Skin Neoplasms | 4 | 2018 | 1679 | 0.59 | Why? |
| Glycoproteins | 1 | 2020 | 615 | 0.58 | Why? |
| Immunoglobulin E | 1 | 2018 | 557 | 0.57 | Why? |
| Arthritis, Psoriatic | 2 | 2018 | 625 | 0.56 | Why? |
| Intestine, Small | 1 | 2017 | 336 | 0.55 | Why? |
| Alopecia Areata | 1 | 2017 | 140 | 0.55 | Why? |
| Drug Eruptions | 1 | 2018 | 319 | 0.53 | Why? |
| Dermoscopy | 1 | 2018 | 346 | 0.53 | Why? |
| Antibodies | 1 | 2020 | 846 | 0.52 | Why? |
| Enterovirus | 1 | 2017 | 402 | 0.52 | Why? |
| Syphilis | 1 | 2017 | 318 | 0.51 | Why? |
| Erythema | 1 | 2017 | 400 | 0.50 | Why? |
| Dermatologic Agents | 1 | 2018 | 489 | 0.48 | Why? |
| Enterobacteriaceae Infections | 1 | 2018 | 529 | 0.47 | Why? |
| Colchicine | 1 | 2019 | 730 | 0.46 | Why? |
| Microbiota | 2 | 2019 | 1240 | 0.45 | Why? |
| Dermatitis, Atopic | 2 | 2019 | 714 | 0.44 | Why? |
| Mindfulness | 1 | 2017 | 437 | 0.44 | Why? |
| Skin | 4 | 2018 | 2096 | 0.42 | Why? |
| Malaria | 1 | 2020 | 1097 | 0.41 | Why? |
| Scleromyxedema | 1 | 2009 | 10 | 0.41 | Why? |
| Granuloma Annulare | 1 | 2009 | 19 | 0.40 | Why? |
| Home Care Services | 1 | 2021 | 1351 | 0.39 | Why? |
| Diabetes Complications | 2 | 2018 | 2358 | 0.38 | Why? |
| Anti-Bacterial Agents | 4 | 2018 | 10083 | 0.37 | Why? |
| Granuloma | 1 | 2009 | 88 | 0.37 | Why? |
| Wounds and Injuries | 1 | 2021 | 1708 | 0.35 | Why? |
| Delayed Diagnosis | 1 | 2018 | 1529 | 0.35 | Why? |
| Autoantibodies | 2 | 2018 | 2094 | 0.34 | Why? |
| DNA, Viral | 1 | 2018 | 2521 | 0.34 | Why? |
| Quality of Life | 3 | 2018 | 9820 | 0.32 | Why? |
| Dermatology | 2 | 2021 | 1999 | 0.31 | Why? |
| Humans | 56 | 2021 | 930598 | 0.30 | Why? |
| Wound Healing | 2 | 2021 | 424 | 0.30 | Why? |
| Alcohol Drinking | 1 | 2017 | 1663 | 0.30 | Why? |
| Hypoglycemic Agents | 1 | 2018 | 2165 | 0.29 | Why? |
| Dermatologists | 2 | 2021 | 435 | 0.28 | Why? |
| Fibroblasts | 2 | 2019 | 839 | 0.27 | Why? |
| Immunocompromised Host | 1 | 2021 | 5150 | 0.27 | Why? |
| Stress, Psychological | 2 | 2018 | 10231 | 0.27 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2017 | 2426 | 0.25 | Why? |
| Female | 28 | 2021 | 380317 | 0.24 | Why? |
| Signal Transduction | 1 | 2019 | 7207 | 0.24 | Why? |
| Surveys and Questionnaires | 4 | 2019 | 43792 | 0.24 | Why? |
| Vaccines | 1 | 2021 | 3692 | 0.23 | Why? |
| Glycosylphosphatidylinositols | 1 | 2020 | 6 | 0.22 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.21 | Why? |
| Italy | 8 | 2021 | 38444 | 0.20 | Why? |
| Dystonin | 1 | 2018 | 4 | 0.19 | Why? |
| Non-Fibrillar Collagens | 1 | 2018 | 9 | 0.19 | Why? |
| Polyhydramnios | 1 | 2018 | 5 | 0.19 | Why? |
| Antibodies, Monoclonal | 1 | 2018 | 8041 | 0.19 | Why? |
| Muscle Hypotonia | 1 | 2018 | 16 | 0.19 | Why? |
| Preconception Care | 1 | 2018 | 49 | 0.19 | Why? |
| Inflammation | 2 | 2019 | 13255 | 0.19 | Why? |
| Apgar Score | 1 | 2018 | 77 | 0.19 | Why? |
| Galactans | 1 | 2017 | 11 | 0.18 | Why? |
| Porphyria Cutanea Tarda | 1 | 2017 | 8 | 0.18 | Why? |
| Dermis | 1 | 2018 | 35 | 0.18 | Why? |
| Amoxicillin-Potassium Clavulanate Combination | 1 | 2018 | 72 | 0.18 | Why? |
| Plant Gums | 1 | 2017 | 6 | 0.18 | Why? |
| Palate, Soft | 1 | 2017 | 11 | 0.18 | Why? |
| Scleroderma, Localized | 1 | 2017 | 25 | 0.18 | Why? |
| Myofibroblasts | 1 | 2018 | 61 | 0.18 | Why? |
| Neurosyphilis | 1 | 2017 | 17 | 0.18 | Why? |
| Mouth Mucosa | 2 | 2018 | 323 | 0.18 | Why? |
| Gentamicins | 1 | 2018 | 76 | 0.18 | Why? |
| Extracellular Matrix | 1 | 2019 | 189 | 0.18 | Why? |
| Epidermis | 1 | 2018 | 47 | 0.18 | Why? |
| Etanercept | 1 | 2019 | 162 | 0.18 | Why? |
| Serratia Infections | 1 | 2017 | 12 | 0.17 | Why? |
| Education, Continuing | 1 | 2019 | 137 | 0.17 | Why? |
| Prebiotics | 1 | 2017 | 53 | 0.17 | Why? |
| Injections | 1 | 2018 | 237 | 0.17 | Why? |
| Microscopy, Atomic Force | 1 | 2018 | 118 | 0.17 | Why? |
| Cell Transformation, Neoplastic | 1 | 2018 | 191 | 0.17 | Why? |
| Mass Screening | 1 | 2017 | 8005 | 0.17 | Why? |
| Ustekinumab | 1 | 2019 | 216 | 0.17 | Why? |
| Pharyngeal Diseases | 1 | 2017 | 56 | 0.17 | Why? |
| Ciprofloxacin | 1 | 2018 | 130 | 0.17 | Why? |
| Herpesvirus 4, Human | 1 | 2020 | 387 | 0.17 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2018 | 6166 | 0.16 | Why? |
| Remission, Spontaneous | 1 | 2017 | 186 | 0.16 | Why? |
| Infant, Low Birth Weight | 1 | 2018 | 243 | 0.16 | Why? |
| Acetamides | 1 | 2018 | 141 | 0.16 | Why? |
| Acetates | 1 | 2018 | 123 | 0.16 | Why? |
| Biological Factors | 1 | 2020 | 276 | 0.16 | Why? |
| Mannans | 1 | 2017 | 218 | 0.16 | Why? |
| Anti-Allergic Agents | 1 | 2018 | 167 | 0.16 | Why? |
| Neoplasm Invasiveness | 1 | 2018 | 582 | 0.16 | Why? |
| Omalizumab | 1 | 2018 | 158 | 0.15 | Why? |
| Tumor Suppressor Protein p53 | 1 | 2018 | 310 | 0.15 | Why? |
| Diabetes Mellitus | 1 | 2018 | 8207 | 0.15 | Why? |
| Middle Aged | 16 | 2021 | 270681 | 0.15 | Why? |
| Lactation | 1 | 2018 | 361 | 0.15 | Why? |
| Foot | 1 | 2017 | 195 | 0.15 | Why? |
| Janus Kinases | 1 | 2019 | 414 | 0.15 | Why? |
| Foramen Ovale, Patent | 1 | 2018 | 153 | 0.15 | Why? |
| Autoantigens | 1 | 2018 | 388 | 0.15 | Why? |
| Fibrosis | 1 | 2019 | 800 | 0.15 | Why? |
| Family Health | 1 | 2021 | 731 | 0.15 | Why? |
| Chemotherapy, Adjuvant | 1 | 2018 | 606 | 0.15 | Why? |
| Antibodies, Antiphospholipid | 1 | 2020 | 519 | 0.15 | Why? |
| Adalimumab | 1 | 2019 | 389 | 0.14 | Why? |
| Eosinophilia | 1 | 2018 | 292 | 0.14 | Why? |
| Mitral Valve | 1 | 2019 | 342 | 0.14 | Why? |
| Breast | 1 | 2017 | 290 | 0.14 | Why? |
| Immunoglobulins | 1 | 2020 | 811 | 0.14 | Why? |
| Hand Dermatoses | 1 | 2019 | 284 | 0.14 | Why? |
| Adult | 14 | 2021 | 244371 | 0.14 | Why? |
| Heart Valve Diseases | 1 | 2019 | 355 | 0.14 | Why? |
| Dermatitis, Occupational | 1 | 2019 | 310 | 0.14 | Why? |
| Breath Tests | 1 | 2017 | 338 | 0.14 | Why? |
| Antibodies, Bacterial | 1 | 2018 | 510 | 0.13 | Why? |
| Quarantine | 1 | 2021 | 18418 | 0.13 | Why? |
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2013 | 46 | 0.13 | Why? |
| Graft vs Host Disease | 1 | 2017 | 501 | 0.13 | Why? |
| Purines | 1 | 2019 | 816 | 0.13 | Why? |
| Catheter-Related Infections | 1 | 2017 | 381 | 0.13 | Why? |
| Azetidines | 1 | 2019 | 722 | 0.13 | Why? |
| Antigens, CD34 | 1 | 2013 | 125 | 0.12 | Why? |
| Male | 16 | 2021 | 367725 | 0.12 | Why? |
| Cardiovascular Diseases | 1 | 2018 | 11497 | 0.12 | Why? |
| Hand | 1 | 2017 | 449 | 0.12 | Why? |
| Immunoglobulin G | 4 | 2020 | 21571 | 0.12 | Why? |
| Gestational Age | 1 | 2018 | 1488 | 0.12 | Why? |
| Aged | 12 | 2021 | 215776 | 0.12 | Why? |
| Abortion, Spontaneous | 1 | 2018 | 776 | 0.12 | Why? |
| Drug Administration Schedule | 1 | 2019 | 2324 | 0.12 | Why? |
| Diagnosis, Differential | 3 | 2018 | 7220 | 0.11 | Why? |
| Immunosuppressive Agents | 2 | 2021 | 6331 | 0.11 | Why? |
| T-Lymphocytes, Regulatory | 1 | 2017 | 698 | 0.11 | Why? |
| Lymphadenopathy | 1 | 2017 | 444 | 0.11 | Why? |
| ABO Blood-Group System | 1 | 2020 | 995 | 0.11 | Why? |
| Africa | 1 | 2020 | 2986 | 0.11 | Why? |
| Urticaria | 1 | 2017 | 472 | 0.11 | Why? |
| Continuity of Patient Care | 1 | 2021 | 1574 | 0.11 | Why? |
| Sulfonamides | 1 | 2019 | 1294 | 0.10 | Why? |
| Immune System | 1 | 2020 | 1479 | 0.10 | Why? |
| Cooperative Behavior | 1 | 2018 | 1216 | 0.10 | Why? |
| Anti-Inflammatory Agents | 2 | 2020 | 6153 | 0.10 | Why? |
| Patient Preference | 1 | 2017 | 750 | 0.10 | Why? |
| Fever | 2 | 2017 | 7795 | 0.10 | Why? |
| Immunoglobulin M | 2 | 2018 | 9091 | 0.10 | Why? |
| Severity of Illness Index | 4 | 2019 | 48226 | 0.10 | Why? |
| Chronic Disease | 3 | 2021 | 5139 | 0.10 | Why? |
| Viremia | 1 | 2017 | 1020 | 0.10 | Why? |
| Atherosclerosis | 1 | 2018 | 768 | 0.10 | Why? |
| Psychometrics | 1 | 2017 | 1269 | 0.10 | Why? |
| Kaplan-Meier Estimate | 1 | 2019 | 4260 | 0.10 | Why? |
| Biomarkers, Tumor | 1 | 2018 | 1314 | 0.10 | Why? |
| Telemedicine | 1 | 2021 | 25032 | 0.10 | Why? |
| Pain | 1 | 2017 | 1084 | 0.10 | Why? |
| Methylprednisolone | 1 | 2020 | 2107 | 0.10 | Why? |
| Aged, 80 and over | 6 | 2021 | 88759 | 0.10 | Why? |
| Paraproteinemias | 1 | 2009 | 61 | 0.10 | Why? |
| Prevalence | 4 | 2018 | 25773 | 0.09 | Why? |
| Pyrazoles | 1 | 2019 | 1791 | 0.09 | Why? |
| Prospective Studies | 3 | 2019 | 43301 | 0.09 | Why? |
| Animals | 4 | 2019 | 78931 | 0.09 | Why? |
| Mucocutaneous Lymph Node Syndrome | 1 | 2020 | 1645 | 0.09 | Why? |
| Drug Resistance, Bacterial | 1 | 2017 | 1414 | 0.09 | Why? |
| Neoplasm Proteins | 1 | 2013 | 501 | 0.09 | Why? |
| Antibodies, Monoclonal, Humanized | 2 | 2019 | 9335 | 0.08 | Why? |
| Long-Term Care | 1 | 2019 | 2047 | 0.08 | Why? |
| Pyrazines | 1 | 2018 | 1783 | 0.08 | Why? |
| Academic Medical Centers | 1 | 2019 | 3088 | 0.08 | Why? |
| Proportional Hazards Models | 1 | 2019 | 6543 | 0.08 | Why? |
| Pregnancy | 2 | 2018 | 23879 | 0.08 | Why? |
| Genetic Predisposition to Disease | 1 | 2020 | 4027 | 0.07 | Why? |
| Patient Satisfaction | 1 | 2018 | 2517 | 0.07 | Why? |
| Pilot Projects | 1 | 2017 | 5182 | 0.07 | Why? |
| Acute Disease | 1 | 2017 | 6029 | 0.07 | Why? |
| Immunity, Cellular | 1 | 2017 | 3614 | 0.07 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2019 | 4545 | 0.07 | Why? |
| Patient Care Team | 1 | 2018 | 3556 | 0.07 | Why? |
| Zoonoses | 1 | 2018 | 3034 | 0.07 | Why? |
| Feces | 1 | 2017 | 4235 | 0.06 | Why? |
| Immunity, Humoral | 1 | 2017 | 4849 | 0.06 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2019 | 5837 | 0.06 | Why? |
| Ultrasonography | 1 | 2018 | 4409 | 0.06 | Why? |
| Risk Factors | 4 | 2019 | 71621 | 0.06 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.06 | Why? |
| Triage | 1 | 2021 | 7151 | 0.06 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.06 | Why? |
| Liver Transplantation | 1 | 2017 | 2864 | 0.06 | Why? |
| Receptors, Interleukin | 1 | 2021 | 83 | 0.05 | Why? |
| Algorithms | 1 | 2018 | 7346 | 0.05 | Why? |
| Risk Assessment | 3 | 2021 | 25439 | 0.05 | Why? |
| Breast Neoplasms | 1 | 2018 | 3633 | 0.05 | Why? |
| Adolescent | 3 | 2020 | 86841 | 0.05 | Why? |
| Lymphocytes | 1 | 2013 | 3056 | 0.05 | Why? |
| Irritants | 1 | 2019 | 28 | 0.05 | Why? |
| Mice | 1 | 2019 | 21357 | 0.05 | Why? |
| Skin Cream | 1 | 2019 | 66 | 0.05 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.05 | Why? |
| S100 Calcium-Binding Protein A4 | 1 | 2018 | 14 | 0.05 | Why? |
| Physicians | 1 | 2018 | 4214 | 0.05 | Why? |
| Emollients | 1 | 2019 | 108 | 0.05 | Why? |
| Elasticity | 1 | 2018 | 70 | 0.05 | Why? |
| Muscle, Smooth | 1 | 2018 | 67 | 0.05 | Why? |
| Case-Control Studies | 1 | 2017 | 17671 | 0.04 | Why? |
| Prognosis | 2 | 2019 | 32490 | 0.04 | Why? |
| Respiratory Hypersensitivity | 1 | 2019 | 103 | 0.04 | Why? |
| Actins | 1 | 2018 | 108 | 0.04 | Why? |
| Sunburn | 1 | 2018 | 33 | 0.04 | Why? |
| Stress, Mechanical | 1 | 2018 | 143 | 0.04 | Why? |
| Gloves, Protective | 1 | 2019 | 249 | 0.04 | Why? |
| Leisure Activities | 1 | 2019 | 221 | 0.04 | Why? |
| Viral Load | 1 | 2018 | 15850 | 0.04 | Why? |
| Kidney Transplantation | 1 | 2017 | 5397 | 0.04 | Why? |
| Arthralgia | 1 | 2019 | 173 | 0.04 | Why? |
| Immunoglobulins, Intravenous | 1 | 2009 | 2705 | 0.04 | Why? |
| Raynaud Disease | 1 | 2017 | 86 | 0.04 | Why? |
| Biomechanical Phenomena | 1 | 2018 | 291 | 0.04 | Why? |
| Infant, Newborn | 1 | 2018 | 23105 | 0.04 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.04 | Why? |
| Antibodies, Viral | 2 | 2020 | 51949 | 0.04 | Why? |
| Interleukin-17 | 1 | 2021 | 602 | 0.04 | Why? |
| Cytokines | 1 | 2018 | 15010 | 0.04 | Why? |
| Arthritis | 1 | 2019 | 288 | 0.04 | Why? |
| Young Adult | 3 | 2021 | 93724 | 0.03 | Why? |
| Retrospective Studies | 4 | 2018 | 105322 | 0.03 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.03 | Why? |
| Myalgia | 1 | 2019 | 1015 | 0.03 | Why? |
| Allergens | 1 | 2019 | 728 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2021 | 27595 | 0.03 | Why? |
| Treatment Outcome | 1 | 2018 | 51732 | 0.03 | Why? |
| Program Evaluation | 1 | 2019 | 1929 | 0.03 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2021 | 2483 | 0.03 | Why? |
| Sex Distribution | 1 | 2017 | 2083 | 0.02 | Why? |
| Pharynx | 1 | 2017 | 1544 | 0.02 | Why? |
| Hand Disinfection | 1 | 2019 | 1671 | 0.02 | Why? |
| Health Personnel | 1 | 2019 | 29646 | 0.02 | Why? |
| Biopsy | 1 | 2018 | 2811 | 0.02 | Why? |
| Age Distribution | 1 | 2017 | 3567 | 0.02 | Why? |
| Gene Expression | 1 | 2018 | 3332 | 0.02 | Why? |
| Cells, Cultured | 1 | 2018 | 5835 | 0.02 | Why? |
| Ambulatory Care Facilities | 1 | 2017 | 2063 | 0.02 | Why? |
| Perception | 1 | 2017 | 2827 | 0.02 | Why? |
| Disease Susceptibility | 1 | 2019 | 4002 | 0.02 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.02 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2019 | 17020 | 0.01 | Why? |
| Incidence | 1 | 2021 | 25622 | 0.01 | Why? |
| Registries | 1 | 2017 | 12327 | 0.01 | Why? |
| Obesity | 1 | 2018 | 7388 | 0.01 | Why? |
| Time Factors | 1 | 2019 | 31397 | 0.01 | Why? |
| Child, Preschool | 1 | 2017 | 36283 | 0.01 | Why? |
| Child | 1 | 2017 | 70012 | 0.01 | Why? |